Home › Precursor T-Cell Lymphoblastic Leukemia-Lymphoma › Georgia › Atlanta
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma clinical trials in Atlanta, GA
3 studies for Precursor T-Cell Lymphoblastic Leukemia-Lymphoma are looking for participants at sites in and around Atlanta (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Testing the Addition of an Anti-cancer Drug, Lenalidomide, to the Usual Combination Chemotherapy Treatment ("EPOCH") for Adult T-Cell Leukemia-Lymphoma (ATLL)
RecruitingPhase 1
- Emory University Hospital Midtown, Atlanta
- Emory University Hospital/Winship Cancer Institute, Atlanta
A Phase 2 Study of WU-CART-007, an Anti-CD7 Allogeneic CAR-T Cell Therapy in T-Cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma (T-RRex)
RecruitingPhase 2
- Children's Hospital of Atlanta, Atlanta
A Registry for People With T-cell Lymphoma
RecruitingObservational study
- Emory University (Data Collection Only), Atlanta
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma trials in other cities
- Houston, TX8 studies
- New York City, NY6 studies
- Washington, DC5 studies
- Columbus, OH5 studies
- St. Louis, MO4 studies
- Boston, MA3 studies
- Queens, NY3 studies
- Edison, NJ3 studies
- Staten Island, NY3 studies
- Philadelphia, PA3 studies
- East Norwalk, CT3 studies
- Baldwin Park, CA3 studies
Other studies in Atlanta
- Cancer (all types)49 studies
- Non-Small Cell Lung Cancer48 studies
- Multiple Myeloma42 studies
- Breast Cancer42 studies
- Prostate Cancer36 studies
- Acute Myeloid Leukemia30 studies
- Metastatic Cancer29 studies
- Ovarian Cancer29 studies
- Colorectal Cancer29 studies
- Lung Cancer28 studies
- Obesity26 studies
- Major Depressive Disorder24 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.